Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ALKS
ALKS News & Events
-
Add to Watchlist
Trade ALKS Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ALKS News
Arcturus Therapeutics Shares Rise 5.7% Following Collaboration with Thermo Fisher
4d ago
NASDAQ.COM
Alkermes Shares Plunge 31% After Phase 2 Study Results
Jun 17 2026
seekingalpha
Alkermes Reports Positive Phase 2 Results for Alixorexton in Narcolepsy Type 2
Jun 17 2026
Newsfilter
Alkermes Receives Orphan Drug Designation for Alixorexton
Jun 15 2026
NASDAQ.COM
Alkermes Receives FDA Orphan Drug Designation
Jun 11 2026
seekingalpha
Alkermes' Lumryz Achieves Key Trial Milestone for Sleep Disorder
May 12 2026
seekingalpha
Alkermes Q1 Earnings Announcement Scheduled
May 04 2026
seekingalpha
Analysis of XBI ETF Trading Dynamics
Apr 07 2026
NASDAQ.COM
Show More News
ALKS Events
No data
ALKS Monitor News
Alkermes' Lumryz Achieves Key Trial Milestone for Sleep Disorder
May 12 2026
Alkermes Reports Q4 Earnings Decline Amid Market Challenges
Feb 25 2026
ALKS Earnings Analysis
No Data
People Also Watch
